According to the 2016 World Health Organization (WHO) classification of Central Nervous System (CNS) tumors, lower-grade gliomas are divided into isocitrate dehydrogenase (IDH)-mutant gliomas and IDH-wildtype gliomas. This evidence concerns the gene IDH3A and glioma.